Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.
Used in medical settings for over 20 years, Sterilair is now being used in a wide range of close-contact environments to maintain healthy air quality.
Karina Malhotra, founder and MD, Acumentice, explores how technology is being used to solve the elective care conundrum and to what extent emerging tech can make a credible difference on the front line.
The UK removed people with moderate forms of asthma from the high-priority group for vaccination, which pushes their vaccination date past April.
Research found that the supported housing and integrated mental health system could save the NHS £950 million if used as a national strategy for social care.
Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.
Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
Here, we assess some of the most common side effects of the Pfizer and BioNTech COVID-19 vaccine.
People living with HIV can now get a COVID vaccine without having to tell the doctor their status - right now, the stigma is holding some back from coming forward to get their vaccination.
As part of the government's roadmap to ease lockdown restrictions, care home residents will be allowed one indoor visitor from the 8th of March.
The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.
A new report published in The Lancet investigates why 43% of HIV deaths in 2018 happened in the Black community, with policy solutions for the ongoing HIV epidemic.
The Sinovac COVID vaccine was revealed to be working at 50.4% efficacy by the Butantan Institute last month, but new data suggests that this could actually be 62%.
Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.
New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.
The UK has received approval from the clinical trials ethics body for the world's first coronavirus human challenge study.
The European Commission has approved a second contract with Moderna to secure an additional 300 million vaccine doses.
We have the essentials of the Marmot Review 2020 for you, including recommended policy measures to tackle health inequalities.
The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.